Amoaku, W M
Chakravarthy, U
Gale, R
Gavin, M
Ghanchi, F http://orcid.org/0000-0002-4448-8162
Gibson, J
Harding, S
Johnston, R L
Kelly, S
Lotery, A http://orcid.org/0000-0001-5541-4305
Mahmood, S
Menon, G
Sivaprasad, S
Talks, J
Tufail, A
Yang, Y
Article History
Received: 15 December 2014
Accepted: 1 March 2015
First Online: 17 April 2015
Competing interests
: WA has provided consultancy services to Alcon, Allergan, Bayer, Novartis and Thrombogenics. He has received travel grants from Allergan, Bayer and Novartis, and honoraria for lectures from Allergan and Novartis. He has participated in clinical trials for which his institution has received funding from Allergan, Novartis and Pfizer. His institution has further received research grants from Allergan and Novartis for non-clinical studies, and CentreVue (Italy) for clinical studies. The remaining authors declare no conflict of interest.
Free to read: This content has been made available to all.